monoclonal antibodies against human ar (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
monoclonal antibodies against human ar
Monoclonal Antibodies Against Human Ar, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 381 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibodies+against+human+ar/Androgen+Receptor+XP+Rabbit+mAb/pm41662901-64-5-11
Average 96 stars, based on 381 article reviews
Monoclonal Antibodies Against Human Ar, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 381 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monoclonal+antibodies+against+human+ar/Androgen+Receptor+XP+Rabbit+mAb/pm41662901-64-5-11
Average 96 stars, based on 381 article reviews
monoclonal antibodies against human ar - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Incubation:Article Title: Teicoplanin alleviates androgenetic alopecia through inhibition of androgen receptor expression and enhancing dermal papilla cell proliferation. Article Snippet: Androgenetic alopecia (AGA) is a prevalent form of hair loss primarily driven by androgen receptor (AR) signaling.. Currently, therapeutic options for AGA are limited.. In this study, we conducted structure-based virtual screening of 3014 known compounds and identified teicoplanin, a glycopeptide antibiotic, as having potent binding affinity for the AR ligand-binding domain along with inhibition of protein expression. Bioprocessing:Article Title: Teicoplanin alleviates androgenetic alopecia through inhibition of androgen receptor expression and enhancing dermal papilla cell proliferation. Article Snippet: Androgenetic alopecia (AGA) is a prevalent form of hair loss primarily driven by androgen receptor (AR) signaling.. Currently, therapeutic options for AGA are limited.. In this study, we conducted structure-based virtual screening of 3014 known compounds and identified teicoplanin, a glycopeptide antibiotic, as having potent binding affinity for the AR ligand-binding domain along with inhibition of protein expression. Ubiquitin Proteomics:Article Title: Teicoplanin alleviates androgenetic alopecia through inhibition of androgen receptor expression and enhancing dermal papilla cell proliferation. Article Snippet: Androgenetic alopecia (AGA) is a prevalent form of hair loss primarily driven by androgen receptor (AR) signaling.. Currently, therapeutic options for AGA are limited.. In this study, we conducted structure-based virtual screening of 3014 known compounds and identified teicoplanin, a glycopeptide antibiotic, as having potent binding affinity for the AR ligand-binding domain along with inhibition of protein expression. |